Cytori Therapeutics Inc Share Price Nasdaq
Equities
US23283K1051
Biotechnology & Medical Research
Sales 2024 * | 3.4M 272M | Sales 2025 * | 4.28M 342M | Capitalization | 7.44M 595M |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.52B | Net income 2025 * | -22M -1.76B | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.74 x |
P/E ratio 2024 * |
-0.76
x | P/E ratio 2025 * |
-0.92
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Cytori Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 30/09/02 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 05/02/20 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 26/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 30/09/02 |
Richard Hawkins
CHM | Chairman | 75 | 30/11/07 |
Robert Lenk
BRD | Director/Board Member | 75 | 29/02/20 |
1st Jan change | Capi. | |
---|---|---|
+0.50% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.95% | 24.63B | |
-23.07% | 18.2B | |
+28.08% | 12.01B | |
-2.40% | 11.76B | |
+14.56% | 10.4B | |
-5.07% | 9.94B |